{"entity":{"id":"nct07446153","kind":"trial","name":"A Clinical Study of HRS-8364 in the Treatment of Advanced Solid Tumor Subjects","aka":[],"tldr":"A phase 1/2 trial of HRS-8364 Tablet in advanced solid tumours, run by Jiangsu HengRui Medicine Co., Ltd., now recruiting.","summary":"A Clinical Study of HRS-8364 in the Treatment of Advanced Solid Tumor Subjects is a phase 1/2 interventional study registered as NCT07446153 by Jiangsu HengRui Medicine Co., Ltd., with 282 participants planned, started 2026-03-19 and due to reach its primary completion in 2028-12. Interventions recorded: HRS-8364 Tablet.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT07446153","url":"https://clinicaltrials.gov/study/NCT07446153"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["hengrui"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT07446153","phase":"1/2","setting":"An Open Label, Multicenter Phase I/II Clinical Study on the Safety, Tolerability, Pharmacokinetics, and Efficacy of HRS-8364 in the Treatment of Advanced Solid Tumor Subjects","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","enrolled":282,"outcomes":[]},"route":"/trials/nct07446153/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"company":[{"id":"hengrui","kind":"company","name":"Jiangsu Hengrui Pharmaceuticals","route":"/companies/hengrui/"}]}}